http://orcid.org/0000-0001-8053-5512
Figures & data
Table 1. Unit prices for healthcare and non-healthcare costs.
Figure 1. Patient profile.
Table 2. Baseline characteristics of patients in the CDT and control groups.
Table 3. Results of MSSES control, utility and QALY for both the CDT group (n = 79) and the control group (n = 79).
Table 4. Average imputed resource use and costs (Euros) at 6-month follow-up for CDT and control group patients.
Figure 2. Cost-effectiveness plane with bootstrapped ICERS; societal costs and MSSES Control at 6 months. Abbreviation. ICERs, Incremental Cost Effectiveness Ratios.
Table 5. Incremental cost-effectiveness ratios and cost-effectiveness plane distributions between CDT and control groups of 6-month follow-up for MSSES control as outcome.
Figure 3. Cost-effectiveness plane with bootstrapped ICURS: societal costs and Dutch (EQ-5D-5L) QALY at 6 months. Abbreviations. QALY, Quality-Adjusted Life Years; ICURS, Incremental Cost-Utility Ratios.
Figure 4. Cost-effectiveness acceptability curve for the social costs and MSSES Control at 6 months. Abbreviation. ICER, Incremental Cost Effectiveness Ratio.
Figure 5. Cost-effectiveness acceptability curve for societal costs and Dutch (EQ-5D-5L) QALY at 6 months. Abbreviation. ICER, Incremental Cost Effectiveness Ratio.
Table 6. Incremental cost-utility ratios and cost-effectiveness plane distributions between CDT and control groups of follow up 6 months for QALY as outcome.
Data availability statement
Data of the current study is publicly available through G van Mastrigt, the corresponding author of this study.